Back
Viking Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Sell
24
VKTX
Viking Therapeutics
Last Price:
$42.32
Seasonality Move:
21.99%
Sell
45
LLY
Eli Lilly and
Last Price:
$795.08
Seasonality Move:
2.84%
Sell
24
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
-
The current Viking Therapeutics [VKTX] share price is $42.35. The Score for VKTX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
-
The current Eli Lilly and [LLY] share price is $795.67. The Score for LLY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $42.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $795.67The current trend is relatively stagnant and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.05 | Sell |
Relative Strength Index (14 RSI): | 34.2 | Sell |
Chaikin Money Flow: | 146451 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.46 - 52.88) | Sell |
Bollinger Bands (100): | (50.86 - 67.3) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.01 | Sell |
Relative Strength Index (14 RSI): | 50.66 | Buy |
Chaikin Money Flow: | 706693 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (758.82 - 810.34) | Buy |
Bollinger Bands (100): | (794.86 - 929.46) | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.46 | Sell |
20-day SMA: | 47.87 | Sell |
50-day SMA: | 56.89 | Sell |
200-day SMA: | 61.45 | Sell |
8-day EMA: | 43.58 | Sell |
20-day EMA: | 47.31 | Sell |
50-day EMA: | 53.29 | Sell |
200-day EMA: | 54.12 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 778.59 | Buy |
20-day SMA: | 793.92 | Buy |
50-day SMA: | 816.58 | Sell |
200-day SMA: | 838.01 | Sell |
8-day EMA: | 783.81 | Buy |
20-day EMA: | 788.8 | Buy |
50-day EMA: | 812.76 | Sell |
200-day EMA: | 807.43 | Sell |
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.86 per share, and an increase next year of $9.50 per share.
Viking Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |